UNICEF recently presented its strategy for supporting access and affordable pricing to new vaccines for Middle Income Countries at the WHO SAGE (Strategic Advisory Group of Experts on Immunization). Consistent with its equity mandate and agenda, and based on continued engagement with partners at the global, regional and country level, UNICEF's procurement strategy aims at addressing the inequitable access to new vaccines through supporting sustained supply and improved pricing. To support this, UNICEF will be providing aggregated demand forecasts to industry, availability and product information to countries, pooling procurement and trying to establish reference pricing. The intention is that this be a temporary intervention with the aim of countries incorporating these vaccines in their regular vaccine procurement within a few years. At its initial stage, the strategy focuses on supporting the adoption of three comparatively new vaccines in national immunization schedules: human papillomavirus, pneumococcal and rotavirus vaccines.